Effect of ketotifen on human alveolar macrophages

Y Kakuta1, T Kato, H Sasaki

  • 1First Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan.

Insights

Ketotifen, an antiasthmatic drug, inhibits macrophage activation by reducing chemiluminescence and Ca-activated K channel currents. These findings suggest a potential mechanism for ketotifen

Area of Science:

  • Immunopharmacology
  • Cellular Physiology

Background:

  • Human alveolar macrophages play a role in asthma pathogenesis.
  • Understanding drug effects on macrophage activation is crucial for antiasthmatic therapies.

Purpose of the Study:

  • To investigate ketotifen's effects on human alveolar macrophage activation.
  • To explore ketotifen's potential as an effector site for antiasthmatic action.

Main Methods:

  • Studied the impact of ketotifen on macrophage chemiluminescence.
  • Analyzed ketotifen's effect on single-channel Ca-activated K conductance.
  • Used phorbol myristate acetate and zymosan-activated serum for macrophage stimulation.

Main Results:

  • Ketotifen significantly inhibited chemiluminescence induced by phorbol myristate acetate in a dose-dependent manner.
  • Ketotifen also reduced chemiluminescence in macrophages stimulated with zymosan-activated serum.
  • Ketotifen inhibited both large and small Ca-activated K channel currents.

Conclusions:

  • Ketotifen demonstrates inhibitory effects on key macrophage activation pathways.
  • These findings provide a cellular basis for ketotifen's antiasthmatic properties.

Related Concept Videos